Study S000861

Preserving Lean Body Mass During Weight Loss In Elderly Obese Patients With GLP-1 Receptor Agonist Treatment

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record Study Protocol and Statistical Analysis Plan (PDF)Informed Consent Form (PDF)

Registration

Registration: NCT05302596
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: NONE
Status: COMPLETED
Enrollment: 16
Start: 2022-09-01
Primary completion: 2023-10-23
Lead sponsor: State University of New York at Buffalo
Conditions: Obesity; Aging
Interventions: DRUG:Semaglutide Pen Injector
Results posted: TRUE
Individual participant data sharing: NO
Secondary identifiers: NIH:UL1TR001412

Registered primary outcomes

Body Composition as Total Fat Mass/ Total Fat-free Mass Ratio [16 weeks]
Body Weight [16 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.